The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
The cell fate: senescence or quiescence
Abstract
Senescence and quiescence are frequently used as interchangeable terms in the literature unwittingly. Despite the fact that common molecules play role in decision of cell cycle arrest, senescent and quiescent cells have some distinctive phenotypes at both molecular and morphological levels. Thus, in this review we summarized the features of senescence and quiescence with respect to visual characteristics and prominent key molecules. A PubMed research was conducted for the key words; "senescence", "quiescence" and "cell cycle arrest". The results which are related to cell cycle control were selected. The selection criteria of the target articles used for this review included also key cell cycle molecules such as p53, pRB, p21, p16, mTOR, p27, etc. The results were not evaluated statistically. The mechanistic target of rapamycin (mTOR) has been claimed to be key molecule in switching on/off senescence/quiescence. Specifically, although maximal p53 activation blocks mTOR and causes quiescence, partial p53 activation sustains mTOR activity and causes senescence subsequently. In broader perspective, quiescence occurs due to lack of nutrition and growth factors whereas senescence takes place due to aging and serious DNA damages. Contrary to quiescence, senescence is a degenerative process ensuing a certain cell death. We highlighted several differences between senescence and quiescence and their key molecules in this review. Whereas quiescence (cell cycle arrest) is only one half of the senescence, the other half is growth stimulation which causes actual senescence phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, p21CIP1 was among the genes differentially expressed by all senescent cell types and in response to all stimuli, although it was also slightly upregulated in quiescence, concordant with its known involvement in both types of cell-cycle arrest [40].”
From Unmasking Transcriptional Heterogeneity in Senescent Cells (2017) · cites this paper as [40]
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“first described as a loss of proliferation capacity in longterm cultures of fibroblast cells [2].”
BackgroundA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 5×
“p53 (TP53; tumor protein p53) ?G1,G1/S or G2 cell cycle arrests, apoptosis [23, 24, 35] ?G0 arrest, growth inhibition [9]”
BackgroundInfluentialSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 2×
“p53 (TP53; tumor protein p53) ?G1,G1/S or G2 cell cycle arrests, apoptosis [23, 24, 35] ?G0 arrest, growth inhibition [9]”
BackgroundAutophagy mediates the mitotic senescence transition
Young, A. R. J., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J. F. J., Tavaré, S., Arakawa, S., Shimizu, S., Watt, F. M., et al. (2009) · Genes & Development · doi:10.1101/gad.519709 · Cited by 1,078
Geriatric muscle stem cells switch reversible quiescence into senescence
Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Ballestar, E., González, S., Serrano, A. L., et al. (2014) · Nature · doi:10.1038/nature13013 · Cited by 1,010
Direct cell reprogramming is a stochastic process amenable to acceleration
Hanna, J., Saha, K., Pando, B., van Zon, J., Lengner, C. J., Creyghton, M. P., van Oudenaarden, A., & Jaenisch, R. (2009) · Nature · doi:10.1038/nature08592 · Cited by 938
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 2×
“pRB (retinoblastoma 1) ?Cell cycle arrest, induce ROS formation/ apoptosis [17, 32, 38] ?Cell cycle arrest, reduce ROS formation/ apoptosis [33]”
BackgroundTelomerase maintains telomere structure in normal human cells
Kenichi, M., Yu, E. Y., Shilagardi, K., Ben‐Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Seishi, M., DeCaprio, J. A., et al. (2006) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 738
Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.-L., Liu, Y., & Zheng, P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081297 · Cited by 682
A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629
Targeted disruption of the three Rb-related genes leads to loss of G 1 control and immortalization
Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582 · cited 2×
“pRB (retinoblastoma 1) ?Cell cycle arrest, induce ROS formation/ apoptosis [17, 32, 38] ?Cell cycle arrest, reduce ROS formation/ apoptosis [33]”
BackgroundMarkers of cellular senescence. Telomere shortening as a marker of cellular senescence
Bernadotte, A., Mikhelson, V. M., & Spivak, I. M. (2016) · Aging · doi:10.18632/aging.100871 · Cited by 466
Kippin, T. E., Martens, D. J., & van der Kooy, D. (2005) · Genes & Development · doi:10.1101/gad.1272305 · Cited by 442
Many roads lead to oncogene-induced senescence
Courtois-Cox, S., Jones, S. L., & Cichowski, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210950 · Cited by 397 · cited 1×
“As it was previously stated that both p53 and pRB can be activated during quiescence and senescence and in the decision of reversibility of cell cycle arrest, more than just two molecules are required to involve in this complex process mediated by multiple factors including signal level, cell type and microenvironment…”
BackgroundCellular senescence and organismal aging
Jeyapalan, J. C., & Sedivy, J. M. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.001 · Cited by 346
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina, L. G., Leontieva, O. V., Bukreeva, E. I., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100160 · Cited by 278
Small-Molecule Antagonists of p53-MDM2 Binding: Research Tools and Potential Therapeutics
Vassilev, L. T. (2004) · Cell Cycle · doi:10.4161/cc.3.4.801 · Cited by 271
DNA damage-induced type I interferon promotes senescence and inhibits stem cell function
Yu, Q., Katlinskaya, Y. V., Carbone, C. J., Zhao, B., Katlinski, K. V., Zheng, H., Guha, M., Li, N., Chen, Q., Yang, T., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.069 · Cited by 260 · cited 1×
“A recent study has demonstrated that continual DNA damage induced production and accumulation of IFN-beta which promoted senescence through ATM pathway by enhancing DDR signaling level and activating p53 [49].”
BackgroundLoss of linker histone H1 in cellular senescence
Funayama, R., Saito, M., Tanobe, H., & Ishikawa, F. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604005 · Cited by 241 · cited 1×
“position and incorporation of nonhistone proteins into chromatin structure of senescent cells [14, 15], it was asserted that during deep-senescence process, a transition of chromatins from histone to nonhistone status occurs [16] in which DNA replication is completely defective or aberrant DNA molecules are synthesize…”
BackgroundCell cycle arrest is not senescence
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100281 · Cited by 217
The ATM–BID pathway regulates quiescence and survival of haematopoietic stem cells
Maryanovich, M., Oberkovitz, G., Niv, H., Vorobiyov, L., Zaltsman, Y., Brenner, O. J., Lapidot, T., Jung, S., & Gross, A. (2012) · Nature Cell Biology · doi:10.1038/ncb2468 · Cited by 166
Kim, K. S., Kang, K. W., Seu, Y. B., Baek, S., & Kim, J.-R. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.11.004 · Cited by 164
Modelling mammalian cellular quiescence
Yao, G. (2014) · Interface Focus · doi:10.1098/rsfs.2013.0074 · Cited by 164
Leontieva, O. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100265 · Cited by 160
Weak p53 permits senescence during cell cycle arrest
Leontieva, O. V., Gudkov, A. V., & Blagosklonny, M. V. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13584 · Cited by 146
Kovatcheva, M., Liu, D. D., Dickson, M. A., Klein, M. E., O’Connor, R., Wilder, F. O., Socci, N. D., Tap, W. D., Schwartz, G. K., Singer, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3364 · Cited by 142
Oncogene-induced Cellular Senescence
Chandeck, C., & Mooi, W. J. (2010) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181c66f4e · Cited by 141
Status of mTOR Activity May Phenotypically Differentiate Senescence and Quiescence
Cho, S., & Hwang, E. S. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0042-1 · Cited by 120
Stressing the cell cycle in senescence and aging
Chandler, H., & Peters, G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.005 · Cited by 119
ATM Couples Replication Stress and Metabolic Reprogramming during Cellular Senescence
Aird, K. M., Worth, A. J., Snyder, N. W., Lee, J. V., Sivanand, S., Liu, Q., Blair, I. A., Wellen, K. E., & Zhang, R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.014 · Cited by 113
Duan, X., Ponomareva, L. V., Veeranki, S., Panchanathan, R., Dickerson, E., & Choubey, D. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0565 · Cited by 103
Senescence as a general cellular response to stress: A mini-review
Fridlyanskaya, I., Alekseenko, L., & Nikolsky, N. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.09.021 · Cited by 97
Blagosklonny, M. V. (2012) · Autophagy · doi:10.4161/auto.22783 · Cited by 97
Hasegawa, H., Yamada, Y., Iha, H., Tsukasaki, K., Nagai, K., Atogami, S., Sugahara, K., Tsuruda, K., Ishizaki, A., & Kamihira, S. (2009) · Leukemia · doi:10.1038/leu.2009.171 · Cited by 84
Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.
Imai, Y., Takahashi, A., Hanyu, A., Hori, S., Sato, S., Naka, K., Hirao, A., Ohtani, N., & Hara, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.006 · Cited by 84
Mechanisms of interferon-induced cell cycle arrest
Sangfelt, O. (2000) · Frontiers in bioscience · doi:10.2741/sangfelt · Cited by 82
Perucca, P., Cazzalini, O., Madine, M. A., Savio, M., Laskey, R. A., Vannini, V., Prosperi, E., & Stivala, L. A. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7507 · Cited by 78
p27 and Leukemia: Cell Cycle and Beyond
Roy, A., & Banerjee, S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24819 · Cited by 70
Telomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70 · cited 2×
“Additionally, within the organism, senescent cells get hyper-functional than usual, so-called ‘‘senescence-associated secretory phenotype’’ (SASP) by secreting several growth factors, inflammatory molecules (chemokines, cytokines), proteases, extracellular matrix components via autocrine and paracrine means before dri…”
BackgroundHelmbold, H., Komm, N., Deppert, W., & Bohn, W. (2009) · Oncogene · doi:10.1038/onc.2009.222 · Cited by 68
Probing the depths of cellular senescence
Baker, D. J., & Sedivy, J. M. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201305155 · Cited by 65
TIGAR induces p53-mediated cell-cycle arrest by regulation of RB–E2F1 complex
Madan, E., Gogna, R., Kuppusamy, P., Bhatt, M. L. B., Pati, U., & Mahdi, A. A. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.260 · Cited by 64
Lin, S., Chiu, F., Wang, Y., Yen, M., Kao, S., & Hung, S. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.10.002 · Cited by 57
Cooperation between p53 and p130(Rb2) in induction of cellular senescence
Kapic, A., Helmbold, H., Reimer, R. A., Klotzsche, O., Deppert, W., & Bohn, W. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401756 · Cited by 50
Shifting senescence into quiescence by turning up p53
Serrano, M. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13785 · Cited by 50
Leontieva, O. V., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026126 · Cited by 44
Nair, R. R., Bagheri, M., & Saini, D. K. (2014) · Journal of Cell Science · doi:10.1242/jcs.159517 · Cited by 40
p21 and p27 a shared senescence history
Flores, J. M., Martín‐Caballero, J., & García-Fernández, R. A. (2014) · Cell Cycle · doi:10.4161/cc.29147 · Cited by 37
The Heart: Mostly Postmitotic or Mostly Premitotic? Myocyte Cell Cycle, Senescence, and Quiescence
Siddiqi, S., & Sussman, M. A. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.014 · Cited by 27
CDK4/6 inhibitor: from quiescence to senescence
Yoshida, A., & Diehl, J. A. (2015) · Oncoscience · doi:10.18632/oncoscience.256 · Cited by 25
Dulić, V. (2011) · Aging · doi:10.18632/aging.100257 · Cited by 22
Distinct roles for p107 and p130 in Rb-independent cellular senescence
Lehmann, B. D., Brooks, A. M., Paine, M. S., Chappell, W. H., McCubrey, J. A., & Terrian, D. M. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5945 · Cited by 22
Aird, K. M., & Zhang, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4411 · Cited by 15
The epidemiology of cardiovascular disease in older persons
Bush, T. L. (1991) · Aging Clinical and Experimental Research · doi:10.1007/bf03323965 · Cited by 15
mTOR favors senescence over quiescence in p53-arrested cells
Schug, T. T. (2010) · Aging · doi:10.18632/aging.100164 · Cited by 14
Tamaki, S. J., Nye, C., Slorach, E. M., Scharp, D. W., Blau, H. M., Whiteley, P. E., & Pomerantz, J. H. (2014) · BMC Biotechnology · doi:10.1186/1472-6750-14-86 · Cited by 4
Cited by
Unmasking Transcriptional Heterogeneity in Senescent Cells
Hernandez-Segura, A., de Jong, T. V., Melov, S., Guryev, V., Campisi, J., & Demaria, M. (2017) · Current Biology · doi:10.1016/j.cub.2017.07.033 · Cited by 972
“By contrast, p21CIP1 was among the genes differentially expressed by all senescent cell types and in response to all stimuli, although it was also slightly upregulated in quiescence, concordant with its known involvement in both types of cell-cycle arrest [40].”
ResultThe First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic
Zhang, W.-W., Li, L., Li, D., Liu, J., Li, X., Li, W., Xu, X., Zhang, M. J., Chandler, L. A., Lin, H., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.218 · Cited by 318
Inflammation and DNA damage: cause, effect or both
Pezone, A., Olivieri, F., Napoli, M. V., Procopio, A., Avvedimento, E. V., & Gabrielli, A. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00905-1 · Cited by 212
Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce
Li, Q., Hagberg, C. E., Silva Cascales, H., Lang, S., Hyvönen, M. T., Salehzadeh, F., Chen, P., Alexandersson, I., Terezaki, E., Harms, M. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01501-8 · Cited by 178
Evidence and perspectives of cell senescence in neurodegenerative diseases
Si, Z., Sun, L., & Wang, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111327 · Cited by 105
Metadata
- Authors
- Terzi, M. Y., Izmirli, M., & Gogebakan, B.
- Affiliations
- Mustafa Kemal University (TR)
- Venue
- Molecular Biology Reports
- Published
- 2016-08-24
- Volume
- 43
- Issue
- 11
- Pages
- 1213-1220
- ISSN
- 0301-4851 (ISSN-L)
- 1573-4978
- OpenAlex
- W2513855625
- Cited by
- 208
- References
- 62
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 30 · 2023: 24 · 2022: 21 · 2021: 37 · 2020: 16 · 2019: 22 · 2018: 18 · 2017: 21
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Biology Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, quiescent cells, cell cycle arrest, p53, mTOR, p16, p21, p27, retinoblastoma protein, DNA damage, aging, growth promotion, cell death
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Stem Cells, Signal Transduction, Tumor Suppressor Protein p53, Cellular Senescence, TOR Serine-Threonine Kinases, Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.